Research trends in glioma chemoradiotherapy resistance: a bibliometric analysis (2003–2023)
Research on glioma chemoradiotherapy resistance has seen substantial growth, with increasing emphasis on immune modulation, the tumor microenvironment, and novel therapeutic targets such as the androgen receptor. This study represents the first comprehensive bibliometric analysis of this field, providing a detailed overview of research trends and potential directions for future studies. The findings highlight the need for strengthened international collaboration and multidisciplinary approaches to address the challenges of therapeutic resistance in glioma.
Authors
- Changpeng Sun (ORCID: https://orcid.org/0000-0001-9258-7475)
- J.-H. Wu
- Jing Yuan (ORCID: https://orcid.org/0000-0002-3923-925X)
- Peter Ping Lin (ORCID: https://orcid.org/0000-0002-6869-9490)
- Yuntao Lu (ORCID: https://orcid.org/0000-0003-4125-304X)
- Wangzhong Chen
- Wenhua Liu (ORCID: https://orcid.org/0000-0002-1531-2299)
- Shishi Yu
- Yifan Xiong (ORCID: https://orcid.org/0000-0002-0544-049X)
- Lang Lang (ORCID: https://orcid.org/0000-0003-3495-0146)
Institutions
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-02-07
- DOI
- https://doi.org/10.3389/fonc.2025.1539937
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00